Tuesday - January 13, 2026

Architect-Led Design Draws Focus as Sunshine Coast Projects Face Cost Pressures

Residential Architect Sunshine Coast As construction costs rise and development continues across the Sunshine Coast, architect-led design is drawing increased attention. Industry commentary suggests early design involvement may help manage affordability, reduce planning risk, and limit costly project changes. SUNSHINE … Continue reading

Global Neurofibromatosis Type 2 Pipeline Expands With 5+ Companies Advancing 5+ Therapies, Reveals DelveInsight’s Clinical and Developmental Analysis

Neurofibromatosis Type 2 Pipeline Leading Neurofibromatosis Type 2 Companies include Recursion Pharmaceuticals, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics, AstraZeneca, Fosun Pharmaceutical, NFlection Therapeutics, and several other innovators. The global Neurofibromatosis Type 2 (NF2) therapeutic pipeline is witnessing steady expansion, driven … Continue reading

Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Chronic Myeloid Leukaemia Pipeline Insight, 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Myeloid Leukaemia pipeline landscape. It covers the Chronic Myeloid Leukemia pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading

Tendinopathy Market Size in the 7MM is Project to Grow with a Significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Tendonitis Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Tendonitis, historical and forecasted epidemiology as well as the Tendonitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and … Continue reading

Bipolar Disorder Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Bipolar Disorder Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Bipolar Disorder pipeline landscape. It covers the Bipolar Disorder Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

Pre-Eclampsia Clinical Trial Pipeline Accelerates as 5+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Pre-Eclampsia Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pre-Eclampsia pipeline landscape. It covers the Pre-Eclampsia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Pre-Eclampsia Pipeline Therapeutics … Continue reading

Nipocalimab Market Size Forecast and Emerging Insights Signal Strong Growth Outlook Through 2034, estimates DelveInsight

Nipocalimab Market Nipocalimab Overview in approved indications like Myasthenia gravis; as well as potential indications like Fetal erythroblastosis, Neonatal alloimmune thrombocytopenia, Sjogren’s syndrome, Systemic lupus erythematosus and others. The Nipocalimab market is entering a pivotal growth phase, driven by recent … Continue reading